Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Larry Zeitlin

Showing results (71-80 of 96) with videos related to

Pageof 10
Sort By:
Cell Reports|September 1, 2021
Cooperativity mediated by rationally selected combinations of human monoclonal antibodies targeting the henipavirus receptor binding proteinMichael P Doyle, Nurgun Kose, Viktoriya Borisevich, et al.
Science Translational Medicine|April 7, 2017
Therapeutic treatment of Marburg and Ravn virus infection in nonhuman primates with a human monoclonal antibodyChad E Mire, Joan B Geisbert, Viktoriya Borisevich, et al.
JCI Insight|April 12, 2022
Combination therapy with remdesivir and monoclonal antibodies protects nonhuman primates against advanced Sudan virus diseaseRobert W Cross, Zachary A Bornholdt, Abhishek N Prasad, et al.
Science Translational Medicine|April 3, 2024
Therapeutic administration of a cross-reactive mAb targeting the fusion glycoprotein of Nipah virus protects nonhuman primatesLarry Zeitlin, Robert W Cross, Courtney Woolsey, et al.
Mbio|April 16, 2025
Avidity and variable domain spacing strongly influence the therapeutic potency of bispecific antibodies against Crimean-Congo hemorrhagic fever virusAlbert Wang, Stephanie R Monticelli, Ariel S Wirchnianski, et al.
Science Translational Medicine|March 11, 2016
Two-mAb cocktail protects macaques against the Makona variant of Ebola virusXiangguo Qiu, Jonathan Audet, Ming Lv, et al.
Plos Pathogens|October 10, 2015
Correction: Protective mAbs and Cross-Reactive mAbs Raised by Immunization with Engineered Marburg Virus GPsMarnie L Fusco, Takao Hashiguchi, Robyn Cassan, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 10, 2021
Therapy for Argentine hemorrhagic fever in nonhuman primates with a humanized monoclonal antibodyLarry Zeitlin, Robert W Cross, Joan B Geisbert, et al.
Plos Pathogens|June 27, 2015
Protective mAbs and Cross-Reactive mAbs Raised by Immunization with Engineered Marburg Virus GPsMarnie L Fusco, Takao Hashiguchi, Robyn Cassan, et al.
The Journal of Infectious Diseases|July 20, 2023
Long-term Prophylaxis Against Aerosolized Marburg Virus in Nonhuman Primates With an Afucosylated Monoclonal AntibodyDafna Abelson, Jennifer Barajas, Lauren Stuart, et al.
Pageof 10

Showing results (71-80 of 96) with videos related to

Sort By:
Pageof 10
Cell Reports|September 1, 2021
Cooperativity mediated by rationally selected combinations of human monoclonal antibodies targeting the henipavirus receptor binding proteinMichael P Doyle, Nurgun Kose, Viktoriya Borisevich, et al.
Science Translational Medicine|April 7, 2017
Therapeutic treatment of Marburg and Ravn virus infection in nonhuman primates with a human monoclonal antibodyChad E Mire, Joan B Geisbert, Viktoriya Borisevich, et al.
JCI Insight|April 12, 2022
Combination therapy with remdesivir and monoclonal antibodies protects nonhuman primates against advanced Sudan virus diseaseRobert W Cross, Zachary A Bornholdt, Abhishek N Prasad, et al.
Science Translational Medicine|April 3, 2024
Therapeutic administration of a cross-reactive mAb targeting the fusion glycoprotein of Nipah virus protects nonhuman primatesLarry Zeitlin, Robert W Cross, Courtney Woolsey, et al.
Mbio|April 16, 2025
Avidity and variable domain spacing strongly influence the therapeutic potency of bispecific antibodies against Crimean-Congo hemorrhagic fever virusAlbert Wang, Stephanie R Monticelli, Ariel S Wirchnianski, et al.
Science Translational Medicine|March 11, 2016
Two-mAb cocktail protects macaques against the Makona variant of Ebola virusXiangguo Qiu, Jonathan Audet, Ming Lv, et al.
Plos Pathogens|October 10, 2015
Correction: Protective mAbs and Cross-Reactive mAbs Raised by Immunization with Engineered Marburg Virus GPsMarnie L Fusco, Takao Hashiguchi, Robyn Cassan, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 10, 2021
Therapy for Argentine hemorrhagic fever in nonhuman primates with a humanized monoclonal antibodyLarry Zeitlin, Robert W Cross, Joan B Geisbert, et al.
Plos Pathogens|June 27, 2015
Protective mAbs and Cross-Reactive mAbs Raised by Immunization with Engineered Marburg Virus GPsMarnie L Fusco, Takao Hashiguchi, Robyn Cassan, et al.
The Journal of Infectious Diseases|July 20, 2023
Long-term Prophylaxis Against Aerosolized Marburg Virus in Nonhuman Primates With an Afucosylated Monoclonal AntibodyDafna Abelson, Jennifer Barajas, Lauren Stuart, et al.
Pageof 10